New reports show next-level growth for Nucleic Acid Amplification Testing (NAAT) Market

1
Nucleic Acid Amplification Testing (NAAT) Market
To Reach USD 4.549 Billion By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
High demand for advanced diagnostic techniques,
increasing investment in the field of
diagnostics, favorable initiatives by governments
all over the globe, extensive range of
applications, growing demand from blood banks and
transfusion centers, technological development in
healthcare sector are key factors contributing to
high CAGR of Nucleic Acid Amplification Testing
during forecast period. According to the
current analysis of Reports and Data, the global
Nucleic Acid Amplification Testing (NAAT) market
was valued at USD 2.315 Billion in 2018 and is
expected to reach USD 4.549 Billion by year 2026,
at a CAGR of 8.8 .
3
Our Approach
Market Summary

• The study covers Nucleic acid which a complex
  organic substance essential to all forms of life.
  It is present in living cells as RNA and DNA,
  composed of nucleotides linked in a long chain.
  Whereas, Nucleic acid amplification testing is a
  method of testing the blood to detect pathogen
  causing bacteria or virus in in blood, tissue,
  urine, etc.
• The nucleic acid amplification testing is widely
  used in the field of diagnostics. With market
  players exploring the applications of nucleic
  acid amplification testing, and it is expected to
  be adopted in new disease fields for the
  diagnostics and monitoring purpose. For instance,
  Gen-Probe, Inc., a US based Clinical Diagnostics
  company, introduced three assays based on its
  transcription-mediated amplification technology
  the APTIMA CT assay (ACT), which detects C.
  trachomatis, the APTIMA GC assay (AGC), which
  detects Neisseria gonorrhoeae, and the APTIMA
  COMBO 2 assay (AC2), which detects both
  pathogens.
• Request for a sample of this research report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /2187

4
Our Approach
Market Summary

• Further key findings from the report suggest
• Nucleic Acid Amplification testing market is
  growing at a CAGR of 8 in Asia Pacific followed
  by North America and Europe, with 8.6 and 8.5
  CAGR, respectively. Growing demand for the
  advanced diagnostic measures the globe is the
  prominent factor to accelerate the nucleic acid
  amplification testing market growth during
  forecast period across all regions
• As of 2018, Target Amplification system is the
  dominating Nucleic Acid Amplification Testing
  technique which holds 38.8 of the global
  market. North America regional market is the
  chief revenue generating source for this product
  segment, followed by Europe and Asia-Pacific
  regions.
• Probe amplification systems is expected to grow
  at a CAGR of 8.4 . The market segment will reach
  USD 1.5 Billion mark by 2026.
• Infectious disease application type segment was
  valued at USD 1.03 billion and is expected reach
  USD 1.97 billion by 2026, growing at a CAGR of
  8.7.
• To identify the key trends in the industry, click
  on the link below https//www.reportsanddata.com/
  report-detail/nucleic-acid-amplification-testing-n
  aat-market

5
Our Approach
Market Summary

• Key participants include Siemens Healthcare GmbH,
  Abbott Laboratories, Inc., F. Hoffmann-La Roche
  Ltd, Grifols SA, Becton, Illumina Inc., Dickinson
  and Company, Beckman Coulter Inc., Bio-Rad
  Laboratories, and bioMrieux SA
• For the purpose of this report, Reports and Data
  has segmented the market on the basis of source,
  product, application, and region
• Technique Type (Revenue, USD Million 20162026)
• Target Amplification
• Probe Amplification
• Signal Amplification

6
Our Approach

• Application Type (Revenue, USD Million
  20162026)
• Infectious Diseases
• Cancer
• Personalized Medicine
• Genetic
• Regional Outlook (Revenue in USD Million
  20162026)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Rest of the Europe
• Order Now https//www.reportsanddata.com/checkout
  -form/2187

7
About Us
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com